Last month Astra Zeneca released a whole load of pre-clinical cancer data to the public. It’s a great move towards pharmacotransparency. However, their extensive ‘AI’ causality mining subsidiaries have probably identified anything individual researchers may hope to find. Viva la machina!
However, their extensive ‘AI’ causality mining subsidiaries have probably identified anything individual researchers may hope to find.
I think that’s unlikely. Having more data about what drugs do is useful for a lot of individual researchers who have complex models to predict the activity of chemical substances.
Over time algorithm get better and there’s more data to be aggregated.
Last month Astra Zeneca released a whole load of pre-clinical cancer data to the public. It’s a great move towards pharmacotransparency. However, their extensive ‘AI’ causality mining subsidiaries have probably identified anything individual researchers may hope to find. Viva la machina!
I think that’s unlikely. Having more data about what drugs do is useful for a lot of individual researchers who have complex models to predict the activity of chemical substances.
Over time algorithm get better and there’s more data to be aggregated.
Didn’t think of that, cheers.